Chilton Capital Management LLC Procept Bio Robotics Corp Transaction History
Chilton Capital Management LLC
- $2.34 Billion
- Q3 2024
A detailed history of Chilton Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chilton Capital Management LLC holds 125 shares of PRCT stock, worth $11,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$11,587
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$449 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$323 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$142 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$115 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$109 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.13B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...